Fielmann Aktiengesellschaft (FIE.DE)
EUR 44.15
(1.38%)
EUR 44.15
(1.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 403.8 Million EUR | 38.37% |
| 2022 | 346.99 Million EUR | -13.39% |
| 2021 | 389.77 Million EUR | 19.32% |
| 2020 | 328.69 Million EUR | -12.6% |
| 2019 | 385.18 Million EUR | 30.08% |
| 2018 | 295.79 Million EUR | 1.5% |
| 2017 | 290.7 Million EUR | 3.27% |
| 2016 | 281.25 Million EUR | 1.11% |
| 2015 | 280.15 Million EUR | 5.47% |
| 2014 | 265.63 Million EUR | 12.77% |
| 2013 | 234.44 Million EUR | 8.27% |
| 2012 | 217.57 Million EUR | 5.37% |
| 2011 | 206.49 Million EUR | 0.23% |
| 2010 | 202.47 Million EUR | 6.88% |
| 2009 | 197.43 Million EUR | -0.06% |
| 2008 | 186.95 Million EUR | 17.07% |
| 2007 | 164.75 Million EUR | -47.8% |
| 2006 | 315.59 Million EUR | -46.97% |
| 2005 | 119.77 Million EUR | 967.71% |
| 2004 | 55.74 Million EUR | -21.44% |
| 2003 | 70.96 Million EUR | 6.4% |
| 2002 | 66.68 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 118.31 Million EUR | 5.13% |
| 2024 Q1 | 114.87 Million EUR | 227.05% |
| 2023 Q4 | 35.12 Million EUR | -72.2% |
| 2023 Q3 | 126.34 Million EUR | 24.22% |
| 2023 Q2 | 101.71 Million EUR | -3.11% |
| 2023 FY | - EUR | 38.37% |
| 2023 Q1 | 104.97 Million EUR | 34.72% |
| 2022 Q3 | 95.69 Million EUR | 15.75% |
| 2022 FY | - EUR | -13.39% |
| 2022 Q2 | 82.67 Million EUR | -10.69% |
| 2022 Q1 | 92.56 Million EUR | 158.97% |
| 2022 Q4 | 77.91 Million EUR | -18.58% |
| 2021 Q4 | 35.74 Million EUR | -72.96% |
| 2021 FY | - EUR | 19.32% |
| 2021 Q1 | 82.91 Million EUR | 41.32% |
| 2021 Q2 | 99.06 Million EUR | 19.48% |
| 2021 Q3 | 132.21 Million EUR | 33.46% |
| 2020 Q1 | 84.52 Million EUR | -71.28% |
| 2020 Q2 | 55.64 Million EUR | -34.17% |
| 2020 Q3 | 131.06 Million EUR | 135.56% |
| 2020 FY | - EUR | -12.6% |
| 2020 Q4 | 58.67 Million EUR | -55.23% |
| 2019 Q3 | 111.45 Million EUR | 19.78% |
| 2019 Q2 | 93.04 Million EUR | -20.82% |
| 2019 Q1 | 117.51 Million EUR | 73.81% |
| 2019 FY | - EUR | 30.08% |
| 2019 Q4 | 294.33 Million EUR | 164.09% |
| 2018 Q1 | 72.45 Million EUR | 18.45% |
| 2018 FY | - EUR | 1.5% |
| 2018 Q2 | 65.64 Million EUR | -9.4% |
| 2018 Q3 | 91.21 Million EUR | 38.96% |
| 2018 Q4 | 67.61 Million EUR | -25.88% |
| 2017 Q2 | 73.36 Million EUR | 3.05% |
| 2017 Q3 | 86.81 Million EUR | 18.33% |
| 2017 Q4 | 61.16 Million EUR | -29.54% |
| 2017 Q1 | 71.19 Million EUR | 5.72% |
| 2017 FY | - EUR | 3.27% |
| 2016 Q4 | 67.34 Million EUR | -15.91% |
| 2016 Q3 | 80.08 Million EUR | 10.78% |
| 2016 Q2 | 72.29 Million EUR | 13.77% |
| 2016 Q1 | 63.54 Million EUR | 9.54% |
| 2016 FY | - EUR | 1.11% |
| 2015 Q2 | 62.65 Million EUR | -13.34% |
| 2015 Q4 | 58.01 Million EUR | -32.98% |
| 2015 Q3 | 86.55 Million EUR | 38.14% |
| 2015 FY | - EUR | 5.47% |
| 2015 Q1 | 72.29 Million EUR | 22.04% |
| 2014 Q2 | 57.91 Million EUR | -14.74% |
| 2014 Q3 | 79.82 Million EUR | 37.83% |
| 2014 Q4 | 59.24 Million EUR | -25.78% |
| 2014 FY | - EUR | 12.77% |
| 2014 Q1 | 67.92 Million EUR | 20.08% |
| 2013 Q3 | 69.35 Million EUR | 29.53% |
| 2013 Q1 | 55.76 Million EUR | 14.0% |
| 2013 FY | - EUR | 8.27% |
| 2013 Q4 | 56.56 Million EUR | -18.44% |
| 2013 Q2 | 53.54 Million EUR | -3.98% |
| 2012 FY | - EUR | 5.37% |
| 2012 Q1 | 55.98 Million EUR | 42.93% |
| 2012 Q2 | 51.16 Million EUR | -8.61% |
| 2012 Q3 | 63.05 Million EUR | 23.24% |
| 2012 Q4 | 48.91 Million EUR | -22.42% |
| 2011 Q3 | 62.64 Million EUR | 20.79% |
| 2011 Q2 | 51.86 Million EUR | -1.8% |
| 2011 Q1 | 52.81 Million EUR | 7.51% |
| 2011 FY | - EUR | 0.23% |
| 2011 Q4 | 39.16 Million EUR | -37.48% |
| 2010 FY | - EUR | 6.88% |
| 2010 Q4 | 49.12 Million EUR | -18.14% |
| 2010 Q3 | 60.01 Million EUR | 20.58% |
| 2010 Q2 | 49.77 Million EUR | 10.18% |
| 2010 Q1 | 45.17 Million EUR | -7.4% |
| 2009 Q1 | 40.09 Million EUR | 0.0% |
| 2009 Q2 | 46.01 Million EUR | 14.77% |
| 2009 Q4 | 48.78 Million EUR | -11.04% |
| 2009 FY | - EUR | -0.06% |
| 2009 Q3 | 54.83 Million EUR | 19.17% |
| 2008 FY | - EUR | 17.07% |
| 2007 FY | - EUR | -47.8% |
| 2006 FY | - EUR | -46.97% |
| 2005 FY | - EUR | 967.71% |
| 2004 FY | - EUR | -21.44% |
| 2003 FY | - EUR | 6.4% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 227.64 Million EUR | -77.384% |
| Carl Zeiss Meditec AG | 502.77 Million EUR | 19.684% |
| Gerresheimer AG | 400.56 Million EUR | -0.809% |
| Sartorius Aktiengesellschaft | 920.1 Million EUR | 56.113% |
| Sartorius Aktiengesellschaft | 920.1 Million EUR | 56.113% |